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ABSTRACT
Mandibular reconstruction to restore functions and aesthetics after mandibular resection remains a major surgical 
challenge. This type of reconstruction using non-vascularized autogenous bone graft harvested from iliac bone has been 
popular given that this bone is numerous and donor site morbidity can be minimized, however, it is highly resorbable. 
Local application of bisphosphonate by immersing bone graft in biphosphonate manages to inhibit bone graft resorption 
prior to the formation of new bone to support the osteogenesis and osteointegration of bone grafts. This paper aimed 
at examining the positive results of iliac bone graft osteogenesis and osteointegration following local application of 
bisphosphonate in mandibular reconstruction. A 22-year-old female patient came with a complaint of painless right 
cheek mass that has swollen slowly since 2 years. Radiographic examination showed cloudy radiolucent images in the 
right mandibular corpus to the right mandibular ramus, while histopathological examination indicated ossifying fibroma. 
Patient underwent mandibular resection followed by iliac bone graft-based mandibular reconstruction. Bone graft was 
immersed with bisphosphonate (zoledronate acid 0.005 mg /ml) for 3 minutes, then rinsed with saline for 3 minutes, 
followed by fixing bone graft on the reconstruction plate. Postoperative follow up in the 36th week showed no signs of 
infection and dehiscence in the surgery site, and the radiographic examination indicated signs of osteogenesis and 
osteointegration of mandibular bone graft. Local application of biphosponate on bone graft promotes favorable results of 
osteogenesis and osteointegration in mandibular reconstruction.
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INTRODUCTION
Mandible is an essential anatomical structure 
for the physiological and aesthetic functions of 
humans. Therefore, any mandibular defects caused 
by tumors, malignancy, trauma, osteomyelitis, and 
osteoradionecrosis will considerably affect patient’s 
quality of life. Hemimandibulectomy, a type of 
mandibular resection may result in mandibular 
defects leading to mandibular dysfunctions.1 The 
mandibular defects after hemimandibulectomy 
require reconstructions to restore mandibular 
aesthetics and functions.2
Mandibular reconstruction can be done by 
using reconstruction plate and iliac bone-derived 
non vascularized autogenous bone graft.3 The 
plate mostly used for mandibular reconstruction 
is a rigid plate that is applied along the inferior 
mandibular margin.4 Among the advantages of 
non-vascularized autogenous bone graft involving 
iliac bone include the availability in large quantities 
(50 - 90 cm3), shorter surgical and recovery 
period, no need for microvascular surgery skills, 
simultaneous surgery by 2 teams, minimal donor 
site morbidity, minimal patient’s scar, various forms 
of harvest (block or particulate, cortical and cortico-
cancellous), while the disadvantages are weak 
osteogenesis and excessive resorption in defects 
over 6 cm caused by the origin of endochondral and 
cortico-cancellous morphology.5,6
Biphosponate is a preparation for minimizing 
osteoclast activity when in contact with bone surfaces, 
especially in subjects with active resorption where 
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biphosponate works as a biochemical barrier for bone 
resorption. Biphosponate may also inhibit resorption 
in bone graft. Studies involving experimental animals 
with biphosponate-locally applied bone graft showed 
the ability to protect graft from resorption without 
affecting other skeletal bones.7 
Local application of biphosponate to bone graft 
succeeds in inhibiting excessive bone graft resorption 
and fostering new bone formation (osteogenesis). 
This article reported clinical and radiological 
evaluations of bone graft osteogenesis after local 
application of biphosponate to hemimandibulectomy-
post mandibular reconstruction.
METHODS
A 23-year-old female patient came to the oral 
surgery department of Dr. Sardjito General Hospital 
to check her right cheek swelling and numbness in 
her right lip. Clinical examination showed a facial 
asymmetry; there was swelling in the mandibular 
ramus area which was hard in consistency, and 
there was an area with an increase in excitatory 
threshold on the cheek of the inferior mandibular 
margin and paresthesia in the right lower lip The 
intraoral examination indicated an swelling in the 
rough-surfaced lingual bone of region 44 to 48 with 
the same gingival color as the surrounding tissue 
Figure 1.
Panoramic radiograph showed the presence 
of cloud of smoke in radiolucent lesions in the 
mandibular corpus region until the right mandibular 
ramus along with bone expansion and uneven 
angular inferior margin and resorption of tooth 46 
and 47 roots. Examination of 3D MSCT showed 
lesions in the mandibular ramus to the right 
mandibular subcondyle and bone destruction 
occurred in the corpus lingual side to the right 
mandibular ramus Figure 2. The examination of 
anatomic pathology showed trabecular-arranged 
bone tissue with osteoblastic rimming, connective 
tissue stroma with proliferation of fibroblasts, which 
was declared as ossifying fibroma.
This case was diagnosed as right 
mandibular ossifying fibroma. Right mandibular 
hemimandibulectomy and mandibular 
reconstruction were chosen as the treatment 
involving reconstruction plate and non-vascularized 
autogenous bone graft derived from the iliac bone 
along with local application of biphosponate on 
the bone graft. The surgery was carried out in 
collaboration with the orthopedic department to 
harvest a 3 cm x 5 cm x 1.5 cm iliac graft. 
Hemimandibulectomy was performed by 
cutting the mandible from the tooth region 44, 
followed by mandibular reconstruction with 
mounted reconstruction plate. Harvested iliac 
graft was soaked in biphosponate preparation, 
zoledronate 0.005 mg/ ml for 3 minutes, after which 
it was rinsed with saline. The graft was then fitted 
to the reconstruction plate with the cortical side 
facing the reconstruction plate Figure 3. The patient 
underwent inpatient post-operative treatment for 
4 days and intermaxillary wiring was fixed and 
retained for 6 weeks. 
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Figure 1. (A) Facial asymmetry, (B) Area with an increased excitatory threshold, (C) Area of paresthesia, (D) Swelling 
of uneven-surfaced lingual bone of region 44 to 48 
 
       
Figure 2. (A) Diffuse cloud of smoke lesions on the ascending corpus-ramus in right mandibular angles (red arrow), (B) 
and (C) Lesions of bone destruction in the lingual side of the corpus to the right ascending in the right mandible (red 
arrow). 
 
    
A 
B C 
Hanif, et al: Local application of biphosphonate … 
Figure 1. (A) facial asymmetry, (B) area with an increased excitatory threshold, (C) area of paresthesia, (D) swelling of 
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Figure 2. (A) Diffuse cloud of smoke lesions on the ascending 
corpus-ramus in right mandibular angles (red arrow), (B) and 
(C) lesions of bone destruction in the lingual side of the corpus 
to the right ascending in the right mandible (red arrow).
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Figure 3. (A) hemimandibulectomy-post mandibular segment, 
(B) bicortical iliac bone graft, (C) iliac graft soaked in Zometa for 
3 minutes, subsequently rinsed with 0.9% NaCl, (D) mounted 
bridge plate on healthy bone with a 3-hole 2.4x10mm screw, 
(E) fitting iliac graft into the reconstruction plate.
 
Figure 3. (A) Hemimandibulectomy-post mandibular segment, (B) Bicortical iliac bone graft, (C) Iliac graft soaked in 
Zometa for 3 minutes, subsequently rinsed with 0.9% NaCl, (D) Mounted bridge plate on healthy bone with a 3-hole 
2.4x10mm screw, (E) Fitting iliac graft into the reconstruction plate. 
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Figure 4. (A) panoramic x-ray of mandibular reconstruction taken in week 12 post-opeative (B) panoramic x-ray of 
mandibular reconstruction taken in week 24 post-opeative (C) Panoramic x-ray of mandibular reconstruction taken in 
week 36 post-opeative showed osteointegration in the mandibular bone with graft (red arrow) and signs of 
osteogenesis along the graft (yellow arrow) 
 
DISCUSSION 
Hemimandibulectomy is highly likely to result in mandibular defects. Mandibular reconstruction 
to restore the patient's anatomical function and shape must be done immediately after 
resection.8,9 Hemimandibulectomy, the radical resection along with reconstruction was opted for 
this case by considering lesions with the involvement of the lingual and buccal sides from the 
mandibular corpus to the right mandibular ascending ramus. 
Ossifying fibroma is a benign tumor that belongs to a type of fibro-osseous lesion. 
Women, in their twenties, are more prone to this fibroma than men. Ossifying fibroma is most 
commonly found in the mandible especially in the posterior area or molar region 10.10  
Ossifying fibroma is slow but persistent in nature and causes expansion and the 
thinning of the buccal and lingual cortical layers to the lower mandibular inferior margin. This 
fibroma triggers no pain but paresthesia when occurring in the nerve structures. The oral 
epithelium will remain intact unless there is a secondary infection.10-12  
Lesion of ossifying fibroma must be completely excised from the surrounding bone 
because of the high recurrence risk and proneness to malignancy.13 The possible method for 
treatin  o sifying fibroma is surgical excision for small-sized lesions with clear boundaries, 
whereas large ones require radical surgery by involving the boundaries of surrounding healthy 
tissue and r construction.11,14 Hemimandibulectomy-based radical resection along with 
reconstruction was chosen to fit the condition of bone destruction and recurrence risk. 
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Figure 4. (A) panoramic x-ray of mandibular reconstruction 
take  in week 12 post-opeative, (B) panoramic x-ray of 
mandibular reconstruction taken in week 24 post-opeative, (C) 
panoramic x-ray of mandibular reconstruction taken in week 36 
post-opeative showed osteointegration in the mandibular bone 
with graft (red arrow) and signs of osteogenesis along the graft 
(yellow arrow)
Clinical evaluation in week 6 following the 
removal of the intermaxillary wiring showed neither 
dehiscence nor signs of intraoral and extraoral 
infection and left side occlusion was well formed. 
Evaluation of the panoramic radiographs taken 
in week 12 and 24 postoperative showed that a 
reconstruction plate was fitted to the right mandible 
and a graft image along the reconstruction plate 
with minimal graft resorption was seen. In week 
36 postoperativ , the anoramic radiograph was 
evaluated, resulting in igns of osteointegration in 
the mandibular b ne with graft in the distal area of 
tooth 43, and signs of osteogenesis along the graft 
attach d to the recons ruction plate Figure 4.
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DISCUSSION
Hemimandibulectomy is highly likely to result in 
mandibular defects. Mandibular reconstruction 
to restore the patient’s anatomical function and 
shape must be done immediately after resection.8,9 
Hemimandibulectomy, the radical resection along 
with reconstruction was opted for this case by 
considering lesions with the involvement of the 
lingual and buccal sides from the mandibular corpus 
to the right mandibular ascending ramus.
Ossifying fibroma is a benign tumor that 
belongs to a type of fibro-osseous lesion. Women, 
in their twenties, are more prone to this fibroma than 
men. Ossifying fibroma is most commonly found 
in the mandible especially in the posterior area or 
molar region 10.10 
Ossifying fibroma is slow but persistent in 
nature and causes expansion and the thinning of 
the buccal and lingual cortical layers to the lower 
mandibular inferior margin. This fibroma triggers no 
pain but paresthesia when occurring in the nerve 
structures. The oral epithelium will remain intact 
unless there is a secondary infection.10-12 
Lesion of ossifying fibroma must be completely 
excised from the surrounding bone because of the 
high recurrence risk and proneness to malignancy.13 
The possible method for treating ossifying fibroma 
is surgical excision for small-sized lesions with 
clear boundaries, whereas large ones require 
radical surgery by involving the boundaries of 
surrounding healthy tissue and reconstruction.11,14 
Hemimandibulectomy-based radical resection 
along with reconstruction was chosen to fit the 
condition of bone destruction and recurrence risk.
The opted method of mandibular reconstruction 
was a titanium plate, with non-vascularized 
autogenous bone graft derived from the iliac bone. 
Mandibular reconstruction plates and screw are 
the most widely used alloplastic materials for the 
reconstruction of the mandibular defects. The 
method is an easy, reliable procedure, and can be 
used for subsequent rehabilitation.15,16 
Iliac bone serves as a graft donor for this 
case because it is numerous and relatively low 
in morbidity. Given that iliac bone is far from the 
facial region, it is possible for two teams to operate 
simultaneously for efficient surgery.17
Prior to implantation, iliac bone graft was 
measured and shaped to fit into the reconstruction 
plate. The iliac graft was immersed in zometa 
solution 0.005 mg/ ml for 3 minutes, after which 
it was rinsed with normal saline. Zometa is a 
trademark for biphosponate preparation which 
contains zoledronate, a part of amino biphosponate, 
with nitrogen in the atomic chain of atoms and 
molecule. The local application of zoledronate-
derived biphosponate is expected to inhibit the 
excessive bone graft recession which occur before 
osteogenesis during bone graft. Local application 
of zelodronate 0.005 mg/ ml in bone graft was done 
by immersing the graft for 3 minutes, followed by 
rinsing for 3 minutes in the experimental animal and 
resulted in slow resorption in the bone graft and an 
increase in new bone formation around the graft.18 
Nitrogen-containing biphosponates such 
as pamidronate, olpadronate, ibandronate, 
alendronate, risedronate and zoledronate have 
a working mechanism that inhibits farnesyl 
diphosphate synthesis which causes failure of 
prenylation (fatty acid chain transfer) of various 
intracellular proteins, especially small GTP binding 
protein (Trimeric G-protein). Prenylation failure will 
trigger a premature apoptotic process of osteoclast 
cells resulting in inability for bone resorption.18,19
Experimental studies showed that aplication 
of biphosponate can be performed by systemic 
administration of biphosponate or local aplication 
of biphosponate. One of the problems associated 
with systemic administration of biphosponate is the 
development of microcracks, which might be caused 
by excessive mineralization. Another problem 
associated with systemic bisphosphonate treatment 
is osteonecrosis of the jaw. It was suggested that 
the incidence of osteonecrosis of the jaw is higher 
in zoledronic acid treatment than in treatment using 
other bisphosphonates. Systemic administration of 
bisphosphonates only reach vascularized bone and 
the necrotic, non-vascularized bonegraft can only 
be reached by the bisphosphonate once it has been 
revascularised. Furthermore, blocking necrotic 
bone resorption, as in the case of a bone graft, may 
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require higher local concentrations, which may be 
difficult to achieve with systemic treatment. Such 
problems would be solved if the graft could be 
treated by local aplication of biphosponate before 
implantation.20,21
Experimental studies of bone graft locally 
applied with biphosponate showed the ability to 
protect graft from resorption without any effects on 
other skeletal bones.7 Locally applied biphosponate 
with zometa (zoledronate 0.005mg/ ml) for 3 minutes 
in experimental dogs resulted in an increase in 
new bone formation in the group applied with 
zometa compared to the control group.7,18,22 Local 
application of biphosponate to alveolar bone defect 
is able to minimize alveolar bone resorption and 
improve new bone formation in the alveolar defect 
and foster the regeneration capacity of biomaterials 
and bone density. 
Topical application of amino-biphosponate 
solution to bone defects or post-extraction socket, 
either alone or combined with a bone graft, is a 
risk-free procedure as biphosponate contributes to 
the initial phase of bone healing and is absorbed 
mainly by the attached bone so tiny amount may be 
released into circulation.22 
Unfortunately, there are only few studies 
on local application of biphosponate in humans. 
In the previous study, it was done by immersing 
the allograft bone in 10 ml Bonefos (disodium 
clodronate) in a dose of 60 mg/ ml for 3 minutes then 
rinsed with 500 ml normal saline in pelvic revision 
surgery. The 24th month postoperative control 
showed that rinsing morselized bone graft soaked 
in biphosponate could prevent resorption and 
minimize the risk of mechanical failure, whereas in 
the control group, the graft experienced resorption 
after 3 months.7,20
Radiographic evaluation of post-reconstruction 
mandibular bone graft in the 36th week postoperative 
showed minimal bone graft resorption and signs of 
osteogenesis along the surface of the bone graft 
and osteointegration occurred in the mandibular 
bone with graft in the distal area of tooth 43. The 
clinical evaluation indicated that locally-applied 
biphosponate was proven to minimize complications 
in the soft tissue or hard tissue around the bone graft.
CONCLUSION
Local application of biphosponate by immersing 
iliac bone graft in biphosponate preparations 
used in mandibular reconstruction-post 
hemimandibulectomy is proven to inhibit premature 
bone graft resorption and increase osteogenesis 
along the bone graft surface and osteointegration of 
bone graft. The use of locally-applied biphosponate 
is proven to minimize complications in the soft 
tissue or hard tissue around bone graft.
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